297 related articles for article (PubMed ID: 27753082)
1. Costs and cost-driving factors for acute treatment of adults with status epilepticus: A multicenter cohort study from Germany.
Kortland LM; Alfter A; Bähr O; Carl B; Dodel R; Freiman TM; Hubert K; Jahnke K; Knake S; von Podewils F; Reese JP; Runge U; Senft C; Steinmetz H; Rosenow F; Strzelczyk A
Epilepsia; 2016 Dec; 57(12):2056-2066. PubMed ID: 27753082
[TBL] [Abstract][Full Text] [Related]
2. Costs, length of stay, and mortality of super-refractory status epilepticus: A population-based study from Germany.
Strzelczyk A; Ansorge S; Hapfelmeier J; Bonthapally V; Erder MH; Rosenow F
Epilepsia; 2017 Sep; 58(9):1533-1541. PubMed ID: 28681418
[TBL] [Abstract][Full Text] [Related]
3. Costs and cost-driving factors of acute treatment of status epilepticus in children and adolescents: A cohort study from Germany.
Schubert-Bast S; Lenders C; Kieslich M; Rosenow F; Strzelczyk A
Seizure; 2022 Apr; 97():63-72. PubMed ID: 35344919
[TBL] [Abstract][Full Text] [Related]
4. Burden and epidemiology of status epilepticus in infants, children, and adolescents: A population-based study on German health insurance data.
Schubert-Bast S; Zöllner JP; Ansorge S; Hapfelmeier J; Bonthapally V; Eldar-Lissai A; Rosenow F; Strzelczyk A
Epilepsia; 2019 May; 60(5):911-920. PubMed ID: 30980677
[TBL] [Abstract][Full Text] [Related]
5. Inpatient treatment costs of status epilepticus in adults in Germany.
Strzelczyk A; Knake S; Oertel WH; Rosenow F; Hamer HM
Seizure; 2013 Dec; 22(10):882-5. PubMed ID: 23992788
[TBL] [Abstract][Full Text] [Related]
6. Burden of illness for super-refractory status epilepticus patients.
Beg JM; Anderson TD; Francis K; Meckley LM; Fitzhenry D; Foster T; Sukhtankar S; Kanes SJ; Moura LM
J Med Econ; 2017 Jan; 20(1):45-53. PubMed ID: 27556834
[TBL] [Abstract][Full Text] [Related]
7. Cost of status epilepticus in a tertiary care hospital in India.
Misra UK; Kalita J; Bhoi SK; Dubey D
Seizure; 2015 Sep; 31():94-8. PubMed ID: 26362384
[TBL] [Abstract][Full Text] [Related]
8. Incidence and mortality of super-refractory status epilepticus in adults.
Kantanen AM; Reinikainen M; Parviainen I; Ruokonen E; Ala-Peijari M; Bäcklund T; Koskenkari J; Laitio R; Kälviäinen R
Epilepsy Behav; 2015 Aug; 49():131-4. PubMed ID: 26141934
[TBL] [Abstract][Full Text] [Related]
9. Determinants and predictors of outcome in super refractory status epilepticus--a developing country perspective.
Jayalakshmi S; Ruikar D; Vooturi S; Alladi S; Sahu S; Kaul S; Mohandas S
Epilepsy Res; 2014 Nov; 108(9):1609-17. PubMed ID: 25246354
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of refractory status epilepticus in adults: A retrospective population-based study.
Kantanen AM; Reinikainen M; Parviainen I; Kälviäinen R
Epilepsy Res; 2017 Jul; 133():13-21. PubMed ID: 28402834
[TBL] [Abstract][Full Text] [Related]
11. Refractory and super-refractory status epilepticus in adults: a 9-year cohort study.
Delaj L; Novy J; Ryvlin P; Marchi NA; Rossetti AO
Acta Neurol Scand; 2017 Jan; 135(1):92-99. PubMed ID: 27080243
[TBL] [Abstract][Full Text] [Related]
12. Inpatient medical cost of status epilepticus in children: A national-wide, multicenter study from China.
Wang T; Wang J; Lu G; Ding D; Yan W; Dou Y; Wang B; Zhou Y; Li T; Ma J; Zhou S; Wang Y;
Epilepsy Behav; 2021 Oct; 123():108248. PubMed ID: 34455296
[TBL] [Abstract][Full Text] [Related]
13. Vagus nerve stimulation in refractory and super-refractory status epilepticus - A systematic review.
Dibué-Adjei M; Brigo F; Yamamoto T; Vonck K; Trinka E
Brain Stimul; 2019; 12(5):1101-1110. PubMed ID: 31126871
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with occurrence and outcome of super-refractory status epilepticus.
Madžar D; Knappe RU; Reindl C; Giede-Jeppe A; Sprügel MI; Beuscher V; Gollwitzer S; Hamer HM; Huttner HB
Seizure; 2017 Nov; 52():53-59. PubMed ID: 28963934
[TBL] [Abstract][Full Text] [Related]
15. Estimating the economic burden of status epilepticus to the health care system.
Penberthy LT; Towne A; Garnett LK; Perlin JB; DeLorenzo RJ
Seizure; 2005 Jan; 14(1):46-51. PubMed ID: 15642500
[TBL] [Abstract][Full Text] [Related]
16. Incidence of the different stages of status epilepticus in Eastern Finland: A population-based study.
Kantanen AM; Sairanen J; Kälviäinen R
Epilepsy Behav; 2019 Dec; 101(Pt B):106413. PubMed ID: 31371204
[TBL] [Abstract][Full Text] [Related]
17. Examining health service utilization, hospital treatment cost, and mortality of individuals with epilepsy and status epilepticus in New South Wales, Australia 2012-2016.
Mitchell RJ; Herkes G; Nikpour A; Bleasel A; Shih P; Vagholkar S; Rapport F
Epilepsy Behav; 2018 Feb; 79():9-16. PubMed ID: 29223007
[TBL] [Abstract][Full Text] [Related]
18. Association Between Treatment Progression, Disease Refractoriness, and Burden of Illness Among Hospitalized Patients With Status Epilepticus.
Guterman EL; Betjemann JP; Aimetti A; Li JW; Wang Z; Yin D; Hulihan J; Lyons T; Miyasato G; Strzelczyk A
JAMA Neurol; 2021 May; 78(5):588-595. PubMed ID: 33818596
[TBL] [Abstract][Full Text] [Related]
19. Specific characteristics and current diagnostic and treatment modalities performance of super refractory status epilepticus in children: A comparative study.
Briassoulis G; Stefanogianni C; Zaganas I; Raissaki M; Briassoulis P; Ilia S
Eur J Paediatr Neurol; 2022 Mar; 37():32-39. PubMed ID: 35051734
[TBL] [Abstract][Full Text] [Related]
20. Super-refractory status epilepticus in West China.
Tian L; Li Y; Xue X; Wu M; Liu F; Hao X; Zhou D
Acta Neurol Scand; 2015 Jul; 132(1):1-6. PubMed ID: 25314275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
